Literature DB >> 24323054

Migraine: Differential effects of placebos in migraine clinical trials.

Peer C Tfelt-Hansen1, Anders Hougaard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24323054     DOI： 10.1038/nrneurol.2013.255

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos.

Authors:  A J de Craen; J G Tijssen; J de Gans; J Kleijnen
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

2.  Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators.

Authors:  Peer Tfelt-Hansen; Julio Pascual; Nabih Ramadan; Carl Dahlöf; Domenico D'Amico; Hans-Christopher Diener; Jakob Møller Hansen; Michel Lanteri-Minet; Elisabeth Loder; Douglas McCrory; Sandra Plancade; Todd Schwedt
Journal:  Cephalalgia       Date:  2012-01       Impact factor: 6.292

Review 3.  Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.

Authors:  Karin Meissner; Margrit Fässler; Gerta Rücker; Jos Kleijnen; Asbjorn Hróbjartsson; Antonius Schneider; Gerd Antes; Klaus Linde
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

Review 4.  Topiramate for the prophylaxis of episodic migraine in adults.

Authors:  Mattias Linde; Wim M Mulleners; Edward P Chronicle; Douglas C McCrory
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

5.  The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care.

Authors:  André Pradalier; Michel Lantéri-Minet; Gilles Géraud; Hervé Allain; Christian Lucas; Antonio Delgado
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  The placebo effect in irritable bowel syndrome trials: a meta-analysis.

Authors:  S M Patel; W B Stason; A Legedza; S M Ock; T J Kaptchuk; L Conboy; K Canenguez; J K Park; E Kelly; E Jacobson; C E Kerr; A J Lembo
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

7.  Acupuncture for patients with migraine: a randomized controlled trial.

Authors:  Klaus Linde; Andrea Streng; Susanne Jürgens; Andrea Hoppe; Benno Brinkhaus; Claudia Witt; Stephan Wagenpfeil; Volker Pfaffenrath; Michael G Hammes; Wolfgang Weidenhammer; Stefan N Willich; Dieter Melchart
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

8.  Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.

Authors:  Hans-Christoph Diener; Peer Tfelt-Hansen; Carl Dahlöf; Miguel J A Láinez; Giorgio Sandrini; Shuu-Jiun Wang; Walter Neto; Ujjwalla Vijapurkar; Aiden Doyle; David Jacobs
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

9.  Placebo response in the prophylaxis of migraine: a meta-analysis.

Authors:  Ana Macedo; Josep-E Baños; Magí Farré
Journal:  Eur J Pain       Date:  2007-04-23       Impact factor: 3.931

10.  Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention.

Authors:  Lasse Theis Krogsbøll; Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  BMC Med Res Methodol       Date:  2009-01-05       Impact factor: 4.615
  10 in total
  2 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

2.  White matter tract microstructure of the mPFC-amygdala predicts interindividual differences in placebo response related to treatment in migraine patients.

Authors:  Jixin Liu; Junya Mu; Tao Chen; Ming Zhang; Jie Tian
Journal:  Hum Brain Mapp       Date:  2018-09-05       Impact factor: 5.038
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.